Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

iSpecimen (ISPC) Change in Acquisitions & Divestments (2023 - 2024)

iSpecimen has reported Change in Acquisitions & Divestments over the past 2 years, most recently at $467320.0 for Q2 2024.

For Q2 2024, Change in Acquisitions & Divestments changed N/A year-over-year to $467320.0; the TTM value through Dec 2024 reached $3.2 million, changed N/A, while the annual FY2024 figure was $3.2 million, 70.16% down from the prior year.
Change in Acquisitions & Divestments for Q2 2024 was $467320.0 at iSpecimen, down from $2.7 million in the prior quarter.
Over five years, Change in Acquisitions & Divestments peaked at $5.8 million in Q3 2023 and troughed at $467320.0 in Q2 2024.